SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ting-Ting Gong, Qi-Jun Wu, Emily Vogtmann, Bei Lin, Yong-Lai Wang, Age at menarche and risk of ovarian cancer: A meta-analysis of epidemiological studies, International Journal of Cancer, 2013, 132, 12
  2. 2
    L. Ouldamer, H. Marret, A. Jacquet, J. Denakpo, G. Body, Bénéfices de la conservation ovarienne post ménopausique lors d’une hystérectomie pour pathologie bénigne : mirage ou réalité ?, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2013, 42, 2, 123

    CrossRef

  3. 3
    Long Nguyen, Segundo Joel Cardenas-Goicoechea, Pierre Gordon, Christina Curtin, Mazdak Momeni, Linus Chuang, David Fishman, Biomarkers for early detection of ovarian cancer, Women's Health, 2013, 9, 2, 171

    CrossRef

  4. 4
    C. C. M. Buis, F. E. van Leeuwen, T. M. Mooij, C. W. Burger, Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis, Human Reproduction, 2013, 28, 12, 3358

    CrossRef

  5. 5
    Susanne Schüler, Marvin Ponnath, Jörg Engel, Olaf Ortmann, Ovarian epithelial tumors and reproductive factors: a systematic review, Archives of Gynecology and Obstetrics, 2013, 287, 6, 1187

    CrossRef

  6. 6
    Asma Abro, Saima Kulsoom, Naveeda Riaz, Pharmacophore model generation for microtubule-stabilizing anti-mitotic agents (MSAAs) against ovarian cancer, Medicinal Chemistry Research, 2013, 22, 9, 4322

    CrossRef

  7. 7
    Maria Koutsaki, Apostolos Zaravinos, Demetrios A. Spandidos, Modern Trends into the Epidemiology and Screening of Ovarian Cancer. Genetic Substrate of the Sporadic Form, Pathology & Oncology Research, 2012, 18, 2, 135

    CrossRef

  8. 8
    A. Shin, Y.-M. Song, K.-Y. Yoo, J. Sung, Menstrual factors and cancer risk among Korean women, International Journal of Epidemiology, 2011, 40, 5, 1261

    CrossRef

  9. 9
    K K Tsilidis, N E Allen, T J Key, L Dossus, A Lukanova, K Bakken, E Lund, A Fournier, K Overvad, L Hansen, A Tjønneland, V Fedirko, S Rinaldi, I Romieu, F Clavel-Chapelon, P Engel, R Kaaks, M Schütze, A Steffen, C Bamia, A Trichopoulou, D Zylis, G Masala, V Pala, R Galasso, R Tumino, C Sacerdote, H B Bueno-de-Mesquita, F J B van Duijnhoven, M G M Braem, N C Onland-Moret, I T Gram, L Rodríguez, N Travier, M-J Sánchez, J M Huerta, E Ardanaz, N Larrañaga, K Jirström, J Manjer, A Idahl, N Ohlson, K-T Khaw, N Wareham, T Mouw, T Norat, E Riboli, Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition, British Journal of Cancer, 2011, 105, 9, 1436

    CrossRef

  10. 10
    Hui-Wen Lin, Ying-Yueh Tu, Shiyng Yu Lin, Wei-Ju Su, Wei Li Lin, Wei Zer Lin, Shen-Chi Wu, Yuen-Liang Lai, Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study, The Lancet Oncology, 2011, 12, 9, 900

    CrossRef

  11. 11
    Sandra C. Jones, Christopher A. Magee, Jane Francis, Karen Luxford, Parri Gregory, Helen Zorbas, Donald C. Iverson, Australian women’s awareness of ovarian cancer symptoms, risk and protective factors, and estimates of own risk, Cancer Causes & Control, 2010, 21, 12, 2231

    CrossRef

  12. 12
    N. Palacios, M. Weisskopf, K. Simon, X. Gao, M. Schwarzschild, A. Ascherio, Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women, Parkinsonism & Related Disorders, 2010, 16, 6, 370

    CrossRef

  13. 13
    M. G. M. Braem, N. C. Onland-Moret, P. A. van den Brandt, R. A. Goldbohm, P. H. M. Peeters, R. F. P. M. Kruitwagen, L. J. Schouten, Reproductive and Hormonal Factors in Association With Ovarian Cancer in the Netherlands Cohort Study, American Journal of Epidemiology, 2010, 172, 10, 1181

    CrossRef

  14. 14
    Danielle Vicus, Amy Finch, Barry Rosen, Isabel Fan, Linda Bradley, Ilana Cass, Ping Sun, Beth Karlan, John McLaughlin, Steven A. Narod, Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation, Gynecologic Oncology, 2010, 118, 2, 155

    CrossRef

  15. 15
    Thanasak Sueblinvong, Michael E. Carney, Current Understanding of Risk Factors for Ovarian Cancer, Current Treatment Options in Oncology, 2009, 10, 1-2, 67

    CrossRef

  16. 16
    Margaret A. Gates, Allison F. Vitonis, Shelley S. Tworoger, Bernard Rosner, Linda Titus-Ernstoff, Susan E. Hankinson, Daniel W. Cramer, Flavonoid intake and ovarian cancer risk in a population-based case-control study, International Journal of Cancer, 2009, 124, 8
  17. 17
    Antonio Russo, Valentina Calò, Loredana Bruno, Sergio Rizzo, Viviana Bazan, Gaetana Di Fede, Hereditary ovarian cancer, Critical Reviews in Oncology/Hematology, 2009, 69, 1, 28

    CrossRef

  18. 18
    E. Moberg, E. Hjerpe, R. J. Ehrsson, C. Möller, B. Angelin, Is endometroid cancer of the ovaries a late manifestation of Alström syndrome?, Journal of Internal Medicine, 2009, 265, 2
  19. 19
    James V. Lacey, Mark E. Sherman, Robboy's Pathology of the Female Reproductive Tract, 2009,

    CrossRef

  20. 20
    Inkyung Baik, Mats Lambe, Qin Liu, Lucy Chie, Sven Cnattingius, Lorelei A. Mucci, Tomas Riman, Anders Ekbom, Hans-Olov Adami, Chung-Cheng Hsieh, Birth spacing and maternal risk of invasive epithelial ovarian cancer in a Swedish nationwide cohort, Cancer Causes & Control, 2008, 19, 10, 1131

    CrossRef

  21. 21
    Ajay P Singh, Shantibhusan Senapati, Moorthy P Ponnusamy, Maneesh Jain, Subodh M Lele, John S Davis, Steven Remmenga, Surinder K Batra, Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer, The Lancet Oncology, 2008, 9, 11, 1076

    CrossRef

  22. 22
    Tony G Zreik, Chakib M Ayoub, Antoine Hannoun, Cynthia J Karam, Adnan R Munkarah, Fertility drugs and risk of ovarian cancer: dispelling the myth, Current Opinion in Obstetrics and Gynecology, 2008, 20, 3, 313

    CrossRef

  23. 23
    Bo Zhou, Qingmin Sun, Rihong Cong, Haijuan Gu, Naping Tang, Li Yang, Bin Wang, Hormone replacement therapy and ovarian cancer risk: A meta-analysis, Gynecologic Oncology, 2008, 108, 3, 641

    CrossRef

  24. 24
    Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls, The Lancet, 2008, 371, 9609, 303

    CrossRef

  25. 25
    Fariba Salehi, Lesley Dunfield, Karen P. Phillips, Daniel Krewski, Barbara C. Vanderhyden, Risk Factors for Ovarian Cancer: An Overview with Emphasis on Hormonal Factors, Journal of Toxicology and Environmental Health, Part B, 2008, 11, 3-4, 301

    CrossRef

  26. 26
    A. Jensen, H. Sharif, J. H. Olsen, S. K. Kjaer, Risk of Breast Cancer and Gynecologic Cancers in a Large Population of Nearly 50,000 Infertile Danish Women, American Journal of Epidemiology, 2008, 168, 1, 49

    CrossRef

  27. 27
    Megumi Fujita, Toru Tase, Yoichiro Kakugawa, Shigeko Hoshi, Yoshikazu Nishino, Satoru Nagase, Kiyoshi Ito, Hitoshi Niikura, Nobuo Yaegashi, Yuko Minami, Smoking, Earlier Menarche and Low Parity as Independent Risk Factors for Gynecologic Cancers in Japanese: A Case-Control Study, The Tohoku Journal of Experimental Medicine, 2008, 216, 4, 297

    CrossRef

  28. 28
    Mack Barnes, Hereditary Gynecologic Cancer, 2008,

    CrossRef

  29. 29
    Chel Hun Choi, Tae-Joong Kim, Woo Young Kim, Geung Hwan Ahn, Jeong-Won Lee, Byoung-Gie Kim, Je-Ho Lee, Duk-Soo Bae, Papillary serous carcinoma in ovaries of normal size: A clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma, Gynecologic Oncology, 2007, 105, 3, 762

    CrossRef

  30. 30
    Rebecca Byler Dann, Joseph L. Kelley, Kristin K. Zorn, Strategies for Ovarian Cancer Prevention, Obstetrics and Gynecology Clinics of North America, 2007, 34, 4, 667

    CrossRef

  31. 31
    Susan Jordan, Adèle Green, Penelope Webb, Benign Epithelial Ovarian Tumours—cancer Precursors or Markers for Ovarian Cancer Risk?, Cancer Causes & Control, 2006, 17, 5, 623

    CrossRef

  32. 32
    R.E. BOARD, C.T.P.H. BRUIJNS, A.E. PRONK, W.D.J. RYDER, P.M. WILKINSON, R. WELCH, J.H. SHANKS, G. CONNOLLY, R.J. SLADE, K. REYNOLDS, H.C. KITCHENER, G.C. JAYSON, Stage- and CA125–related survival in patients with epithelial ovarian cancer treated at a cancer center, International Journal of Gynecological Cancer, 2006, 16, S1
  33. 33
    Sergio Pecorelli, Roberto Angioli, Brunella Pasinetti, Giancarlo Tisi, Franco Odicino, Systemic therapy for gynecological neoplasms: Ovary, cervix and endometrium, Update on Cancer Therapeutics, 2006, 1, 4, 515

    CrossRef

  34. 34
    Gudrun Rieck, Alison Fiander, The effect of lifestyle factors on gynaecological cancer, Best Practice & Research Clinical Obstetrics & Gynaecology, 2006, 20, 2, 227

    CrossRef

  35. 35
    Ray M. Merrill, Stephanie Fugal, Lelinneth B. Novilla, Matthew C. Raphael, Cancer risk associated with early and late maternal age at first birth, Gynecologic Oncology, 2005, 96, 3, 583

    CrossRef

  36. 36
    A.E. Guppy, P.D. Nathan, G.J.S. Rustin, Epithelial Ovarian Cancer: A Review of Current Management, Clinical Oncology, 2005, 17, 6, 399

    CrossRef

  37. 37
    A. AURANEN, S. HIETANEN, T. SALMI, S. GRÉNMAN, Hormonal treatments and epithelial ovarian cancer risk, International Journal of Gynecological Cancer, 2005, 15, 5
  38. 38
    Annika Auranen, Honglin Song, Christy Waterfall, Richard A. DiCioccio, Bettina Kuschel, Susanne K. Kjaer, Estrid Hogdall, Claus Hogdall, John Stratton, Alice S. Whittemore, Douglas F. Easton, Bruce A.J. Ponder, Karen L. Novik, Alison M. Dunning, Simon Gayther, Paul D.P. Pharoah, Polymorphisms in DNA repair genes and epithelial ovarian cancer risk, International Journal of Cancer, 2005, 117, 4
  39. 39
    G. L. Gierach, F. Modugno, R. B. Ness, Relations of Gestational Length and Timing and Type of Incomplete Pregnancy to Ovarian Cancer Risk, American Journal of Epidemiology, 2005, 161, 5, 452

    CrossRef

  40. 40
    S. Pecorelli, B. Pasinetti, R. Angioli, G. Favalli, F. Odicino, 2005,

    CrossRef

  41. 41
    Kathleen M. Fairfield, David J. Hunter, Graham A. Colditz, Charles S. Fuchs, Daniel W. Cramer, Frank E. Speizer, Walter C. Willett, Susan E. Hankinson, A prospective study of dietary lactose and ovarian cancer, International Journal of Cancer, 2004, 110, 2
  42. 42
    Christer Borgfeldt, Ellika Andolf, Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis, Acta Obstetricia et Gynecologica Scandinavica, 2004, 83, 4
  43. 43
    G. C. Zografos, M. Panou, N. Panou, Common risk factors of breast and ovarian cancer: recent view, International Journal of Gynecological Cancer, 2004, 14, 5
  44. 44
    Toon Van Gorp, Frederic Amant, Patrick Neven, Ignace Vergote, Phillipe Moerman, Endometriosis and the development of malignant tumours of the pelvis. A review of literature, Best Practice & Research Clinical Obstetrics & Gynaecology, 2004, 18, 2, 349

    CrossRef

  45. 45
    Louise A Brinton, Emmet J Lamb, Kamran S Moghissi, Bert Scoccia, Michelle D Althuis, Jerome E Mabie, Carolyn L Westhoff, Ovarian cancer risk associated with varying causes of infertility, Fertility and Sterility, 2004, 82, 2, 405

    CrossRef

  46. 46
    Tomas Riman, Staffan Nilsson, Ingemar R. Persson, Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies, Acta Obstetricia et Gynecologica Scandinavica, 2004, 83, 9
  47. 47
    M. Steven Piver, Tom S. Frank, Diagnosis and Management of Ovarian Disorders, 2004,

    CrossRef

  48. 48
    Roberta B. Ness, Endometriosis and ovarian cancer: Thoughts on shared pathophysiology, American Journal of Obstetrics and Gynecology, 2003, 189, 1, 280

    CrossRef

  49. 49
    Claire F Verschraegen, Silke Westphalen, Wei Hu, Evelyne Loyer, Andrzej Kudelka, Peter Völker, John Kavanagh, Melissa Steger, Klaus-Dieter Schulz, Günter Emons, Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer, Gynecologic Oncology, 2003, 90, 3, 552

    CrossRef

  50. 50
    Celine M. Vachon, Pamela J. Mink, Carol A. Janney, Thomas A. Sellers, James R. Cerhan, Lynn Hartmann, Aaron R. Folsom, Association of Parity and Ovarian Cancer Risk by Family History of Breast or Ovarian Cancer in a Population-Based Study of Postmenopausal Women, Epidemiology, 2002, 13, 1, 66

    CrossRef

  51. 51
    Susan Harlap, Sara H. Olson, John P. Curtin, Thomas A. Caputo, Christine Nakraseive, Damaris Sanchez, and Xiaonan Xue, Epithelial Ovarian Carcinoma and Fertility of Parents, Epidemiology, 2002, 13, 1, 59

    CrossRef

  52. 52
    K Bergfeldt, B Nilsson, S Einhorn, P Hall, Breast cancer risk in women with a primary ovarian cancer—a case–control study, European Journal of Cancer, 2001, 37, 17, 2229

    CrossRef

  53. 53
    Jacqueline Royar, Heiko Becher, Jenny Chang-Claude, Low-dose oral contraceptives: Protective effect on ovarian cancer risk, International Journal of Cancer, 2001, 95, 6
  54. 54
    R. J. Edmondson, J. M. Monaghan, The epidemiology of ovarian cancer, International Journal of Gynecological Cancer, 2001, 11, 6
  55. 55
    Roberta B. Ness, Jeane Ann Grisso, Carrie Cottreau, Jennifer Klapper, Ron Vergona, James E. Wheeler, Mark Morgan, James J. Schlesselman, Factors Related to Inflammation of the Ovarian Epithelium and Risk of Ovarian Cancer, Epidemiology, 2000, 11, 2, 111

    CrossRef

  56. 56
    Christine H. Holschneider, Jonathan S. Berek, Ovarian cancer: Epidemiology, biology, and prognostic factors, Seminars in Surgical Oncology, 2000, 19, 1
  57. 57
    Dongmei Zhang, William F. Holmes, Shujian Wu, Dianne R. Soprano, Kenneth J. Soprano, Retinoids and ovarian cancer, Journal of Cellular Physiology, 2000, 185, 1
  58. 58
    P González-Diego, G López-Abente, M Pollán, M Ruiz, Time trends in ovarian cancer mortality in Europe (1955–1993), European Journal of Cancer, 2000, 36, 14, 1816

    CrossRef

  59. 59
    Rebecca Troisi, Patricia Hartge, Women and Health, 2000,

    CrossRef

  60. 60
    Günter Emons, John J. Kavanagh, HORMONAL INTERACTIONS IN OVARIAN CANCER, Hematology/Oncology Clinics of North America, 1999, 13, 1, 145

    CrossRef

  61. 61
    R. B. Ness, C. Cottreau, Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer, JNCI Journal of the National Cancer Institute, 1999, 91, 17, 1459

    CrossRef

  62. 62
    Tomas Riman, Ingemar Persson, Staffan Nilsson, Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence, Clinical Endocrinology, 1998, 49, 6
  63. 63
    John A Baron, Gloria Gridley, Elisabete Weiderpass, Olof Nyren, Martha Linet, Venous thromboembolism and cancer, The Lancet, 1998, 351, 9109, 1077

    CrossRef

  64. 64
    GRAHAM A. COLDITZ, JOANN E. MANSON, SUSAN E. HANKINSON, The Nurses' Health Study: 20-Year Contribution to the Understanding of Health Among Women, Journal of Women's Health, 1997, 6, 1, 49

    CrossRef

  65. 65
    Reproductive factors, Cancer Causes & Control, 1996, 7, S1, S29

    CrossRef

  66. 66
    Ivana Rizzuto, Renee F Behrens, Lesley A Smith, Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility, The Cochrane Library,